MedTrace Logo

BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH

NCT04203212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2021-01-12

No results posted yet for this study

Summary

The investigators aim to investigate the effect of menstrual cessation in women with endometriosis treated with GnRH analogs for 6 months on bone mineral density and bone and muscle metabolism parameters and subsequently the effects of menstrual restoration after GnRH analogs discontinuation on the above measured parameters

Conditions

  • Endometriosis
  • Bone Density
  • Muscle
  • Bone Metabolism

Interventions

DRUG

Goserelin Acetate

Goserelin the a GnRH analog that will be administered to achieve menstrual cessation for 6 months

Sponsors & Collaborators

  • 251 Hellenic Air Force & VA General Hospital

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    collaborator OTHER

  • 424 General Military Hospital

    lead OTHER

Principal Investigators

  • Athanasios Anastasilakis, PhD · 424 General Military Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-12-01
Completion
2020-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04203212 on ClinicalTrials.gov